Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.50
Bid: 20.00
Ask: 21.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.00%)
Open: 20.50
High: 20.50
Low: 20.50
Prev. Close: 20.50
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with Smiths Medical

1 Dec 2006 12:23

Inditherm PLC01 December 2006 Press Release 1 December 2006 Inditherm plc ("Inditherm" or "The Company") US Distributorship Agreement with Smiths Medical Critical Care Inditherm plc (AIM: IDM), the provider of innovative heating solutions to thefood, industrial process, utility, medical, construction and sport industries,has signed an exclusive distribution agreement with Smiths Medical CriticalCare, (a Division of Smiths Medical), to distribute Inditherm's patient warmingproducts in the USA. Smiths Medical is a division of Smiths Group plc (FTSE:SMIN.L). Under this agreement, which has a term of at least 3 years, Smiths Medical willsell Inditherm heated mattresses and blankets under their Level 1(R) brand nameto the US medical market. The Inditherm products complement Smiths Medicals'existing range and can be used in a variety of areas, including operating rooms,pre- and post- operative areas and intensive care units. Inditherm's patient warming products are based upon The Company's unique,patented, low voltage conductive polymer technology, which provides uniform,direct heating, resulting in much better thermal transfer performance andadvantages over traditional patient warming methods. Smiths Medical has a well-established market presence in the US patient warmingsector with a large sales team, directed at hospitals throughout the US. Underthe terms of the agreement, sales are targeted to reach up to US$5million in thethird year. Smiths Medical Critical Care has undertaken to place an immediate order forheating mattresses worth at least $275,000 for demonstration stock. These willbe used for sales training early in the New Year and for demonstrations to andevaluations by potential customers. Commenting on the agreement, Inditherm's CEO, Richard Harpum said: "This is amajor step forward for Inditherm and a solid endorsement of our patient warmingtechnology by a world leader in medical products. Smiths Medical makes anexcellent partner, as they have the capability to accelerate our entry into theUS market". As stated in the Company's interim results on 28th September this year, therehas been encouraging progress made across all of the Company's core businessareas, although additional funds are required to continue the development. TheBoard is pursuing various strategic options to secure such funding. - Ends - For further information contact: Inditherm plcRichard Harpum, CEO +44 (0) 1709 761000rharpum@indithermplc.com www.inditherm.comIan Smith, Finance Director +44 (0) 1709 761000ismith@indithermplc.comAbchurchJustin Heath +44 (0) 113 203 1340justin.heath@abchurch-group.com www.abchurch-group.com Editors' Notes Inditherm plc Inditherm plc is an AIM-listed provider of low voltage, cost-effective heatingtechnology. It manufactures, installs and licenses its specialised, patentedheating technology for use in numerous applications that require temperaturemaintenance or frost protection, including industrial, utility, medical,construction, and sports turf heating. The Rotherham-based company operates ina global environment and has a blue-chip customer base. Inditherm's technology uses a carbon-based, electrically conductive polymer,also called Inditherm, to produce a cost-effective, flexible and adaptableheating surface. Powered by a low voltage supply, Inditherm generates uniformheat over its entire surface with no hot spots. Inditherm received US Food & Drug Administration clearance for its patientwarming products In May 2006. Smiths Medical Smiths Medical, a division of Smiths Group plc (LSE: SMIN.L) is aclinically-focused global leader in the design, manufacture, and distribution ofmedical devices used for a variety of therapeutic, diagnostic, and surgicalprocedures. The company's portfolio includes airway management, pain management,temperature management systems, infusion systems, implantable access systems,safety I.V. catheters, critical care monitoring, and insulin delivery systems.This product range offers customers clinical and economical advantages backed byexperience, innovation, and value-added services, including extensive producttraining and support. For more information, please visit http://www.smiths-medical.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Nov 20222:05 pmRNSSecond Price Monitoring Extn
28th Nov 20222:00 pmRNSPrice Monitoring Extension
28th Nov 20229:05 amRNSSecond Price Monitoring Extn
28th Nov 20229:00 amRNSPrice Monitoring Extension
28th Nov 20227:00 amRNSUpdate on Trading
9th Nov 20227:00 amRNSUkraine Order
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
4th Oct 20222:05 pmRNSSecond Price Monitoring Extn
4th Oct 20222:00 pmRNSPrice Monitoring Extension
4th Oct 202211:05 amRNSSecond Price Monitoring Extn
4th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSInterim Results
21st Sep 20227:00 amRNSSignificant Japanese Order
1st Sep 20227:00 amRNSResults date and Investor events
15th Aug 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSCapital Markets Day
30th Jun 202212:58 pmRNSResult of AGM
30th Jun 20227:00 amRNSAGM Statement
10th Jun 20221:00 pmRNSExercise of options and Total Voting Rights
7th Jun 20227:00 amRNS£1.3 million Iraq Order
6th Jun 20227:00 amRNSAnnual Report 2022 and Notice of AGM
24th May 20227:00 amRNSTR1 Notification
20th May 20223:09 pmRNSTR1 Notification
19th May 20227:00 amRNSMello Investor Conference
4th May 20227:00 amRNSFinal Results
25th Apr 20227:05 amRNSInvestor Presentation
8th Apr 20222:21 pmRNSGrant of Options
1st Apr 20227:00 amRNSLaunch of test to avoid hearing loss in neonates
17th Feb 20227:00 amRNSPost Period Trading Update and Notice of Results
14th Feb 20227:00 amRNS$1.37 million Egyptian Order
1st Feb 20229:00 amRNSCenkos Virtual Growth and Innovation Forum
9th Dec 20214:15 pmRNSTR1 Notification
9th Dec 20214:15 pmRNSTR1 Notification
2nd Dec 20217:00 amRNSCapital Markets Day
29th Oct 20213:07 pmRNSDirector/PDMR Shareholding
25th Oct 202110:15 amRNSReplacement: Director/PDMR Shareholding
22nd Oct 20214:35 pmRNSDirector/PDMR Shareholding
20th Oct 20215:02 pmRNSDirector/PDMR Shareholding
5th Oct 20217:00 amRNSInterim Results
4th Oct 20217:00 amRNSTR1 Notification
24th Sep 20217:00 amRNSNotice of Results, Mello and AIM Awards
11th Aug 20217:00 amRNSTrading Update
27th Jul 202110:13 amRNSDirector/PDMR Shareholding
12th Jul 20217:00 amRNSTR1 Notification
25th Jun 202112:43 pmRNSResult of AGM
25th Jun 20217:00 amRNSAGM Statement
23rd Jun 20211:15 pmRNSAGM Notice
22nd Jun 20217:00 amRNSProject WAVE recruits first patient
16th Jun 20219:18 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.